Ono Pharmaceutical (4528) Sustainability Meeting presentation summary

Materiality and growth strategy

• Consolidated US and Europe operations into Deciphera to accelerate global expansion and direct sales capabilities.

• Revised materiality, reducing 18 priorities to 9, focusing on innovative drugs, pipeline expansion, and business domain growth.

• Emphasizes collaboration with top scientists, digital transformation, and global business advancement for next-generation healthcare.

Foundation for sustainable growth

• Implementing global IT infrastructure and digital transformation to support business growth.

• Committed to recruiting and developing diverse talent, fostering an inclusive culture, and ensuring employee well-being.

• Pursuing environmental leadership under "ECO VISION 2050" and robust governance for sustainable growth.

Diversity and human capital initiatives

• Promoting diversity through global HR systems, increased female and mid-career hires, and open job postings.

• Targeting 10% female managers by FY2026 and 20% by FY2031, with structured development and mentoring programs.

• Specialized human resources development exceeds targets, supporting growth strategies and global expansion.